<- Back to digest

JOA - 2026-11-01 - Journal Article

The Limited Utility of Synovial C-Reactive Protein in the Diagnosis of Knee and Hip Periprosthetic Joint Infection: Proposed New Diagnostic Cutoffs.

McCavitt DG, Culler MW, Palmer RC, Iyer AS, Lim MA, Lieberman JR, Heckmann ND

retrospective cohortLOE IIIn = 107 (86 TKA, 21 THA)N/A

Topics

arthroplasty
PMID: 41730395DOI: 10.1016/j.arth.2026.02.030View on PubMed ->

Key Takeaway

The established 6.9 mg/L synovial CRP cutoff yields only 68.8% sensitivity for knee PJI and 75.0% for hip PJI, while Youden-optimized thresholds of 3.43 mg/L (knee) and 2.86 mg/L (hip) improve sensitivity but serum CRP AUC (0.954 hip, 0.910 knee) remains superior to synovial CRP AUC (0.885 hip, 0.910 knee).

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study evaluated the diagnostic performance of synovial CRP at the established 6.9 mg/L threshold versus optimized cutoffs for PJI diagnosis using 2018 ICM criteria in 107 arthroplasty patients. At 6.9 mg/L, synovial CRP sensitivity was 68.8% for knees and 75.0% for hips, with specificity of 97.8% and 92.3% respectively. Youden J-statistic identified lower optimal thresholds (3.43 mg/L knee, 2.86 mg/L hip), but serum CRP AUC was equivalent or superior to synovial CRP at both joints, with strong correlation between synovial and serum CRP (ρ=0.804 knee, ρ=0.800 hip, P<0.001).

Key Limitation

The THA cohort (n=21) is too small to validate joint-specific cutoffs, and the retrospective design with a single-center population limits generalizability of the proposed thresholds.

Original Abstract

BACKGROUND

The utility of synovial C-reactive protein (CRP) in diagnosing periprosthetic joint infection (PJI) remains controversial. This study examined the performance of synovial CRP for PJI diagnosis following total knee arthroplasty and total hip arthroplasty.

METHODS

In total, 107 patients (86 total knee arthroplasty [80.4%], 21 total hip arthroplasty [19.6%]) were included for analysis. Using the 2018 International Consensus Meeting criteria, cases were categorized as positive, inconclusive, or negative for PJI. Per criteria, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of a synovial CRP greater than 6.9 mg/L were calculated. Area under the receiver operating characteristic curve (AUC) analysis was performed, and Youden J-statistic identified an optimal diagnostic threshold. Synovial and serum CRP correlation was examined.

RESULTS

In knees, synovial CRP had a sensitivity of 68.8%, specificity of 97.8%, PPV of 95.7%, NPV of 81.8%, and accuracy of 85.9%. In hips, synovial CRP had a sensitivity of 75.0%, specificity of 92.3%, PPV of 85.7%, NPV of 85.7%, and accuracy of 85.7%. Youden J-statistic identified optimal synovial CRP thresholds of 3.43 mg/L in knees and 2.86 mg/L in hips. Receiver operating characteristic curve analysis of synovial and serum CRP identified AUCs of 0.910 and 0.954 for knees and 0.885 and 0.886 for hips, respectively. Synovial and serum CRP were positively correlated in both knees (ρ = 0.804, P < 0.001) and hips (ρ = 0.800, P < 0.001).

CONCLUSIONS

A synovial CRP threshold of 6.9 mg/L was associated with a low sensitivity and may lead to false-negative results in both knees and hips. While a lower synovial CRP threshold improved sensitivity, serum CRP remained superior by this measure at both the knee and hip. Surgeons should interpret synovial CRP with caution during the diagnostic workup of PJI.